Nasdaq
$1.92▼ 0.52%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $4.7MShares out 2.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
12- 8.19Pre-market26.08.19 21:304Ownership#●●●
Aclarion, Inc.
Aclarion, Inc. insider Amanda M. Williams reported a change in beneficial ownership of securities on August 17, 2026, via SEC Form 4. This filing serves as an official record of the insider's transaction, providing investors with transparency regarding internal equity movements.…more
$1.92-0.52%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.18Pre-market26.08.18 21:304Ownership
Aclarion, Inc.
Aclarion, Inc. insider Gregory A. Gould filed a Form 4 with the SEC on August 18, 2026, reporting changes in beneficial ownership of securities effective August 14, 2026. Investors should review the filing for specific details regarding the insider's transaction activity.…more
$1.92-0.52%vs prev closeView filingShare - 8.17Pre-market26.08.17 21:304Ownership
Aclarion, Inc.
Aclarion, Inc. insider Ryan Bond filed a Form 4 on August 17, 2026, reporting changes in beneficial ownership of securities as of August 13, 2026. This filing serves as an official disclosure of insider equity transactions to the SEC.…more
$1.92-0.52%vs prev closeView filingShare
11 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 5d agoPre-market26.10.20 20:00#●●●#●●●
Aclarion Reports Q3 Scan Volume Growth and Clinical Progress
Aclarion announced an 85% year-over-year increase in scan volumes for the third quarter of 2026. The company is advancing its CLARITY clinical trial and maintains sufficient cash reserves to fund operations through the second half of 2027.…more
$1.92-0.52%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.13Pre-market26.10.13 20:00
●●●●●●●● ●●●●● ●●●●●●
Healthcare technology company Aclarion announced its participation in the 20th Annual LD Micro Main Event scheduled for October 20. The company's management will present its business updates and corporate vision to investors during the conference.…more
$1.92-0.52%vs prev close - 10.8Pre-market26.10.08 20:21
●●●●●●●● ●●●●● ●●●●●●
Aclarion announced that patient enrollment for its CLARITY trial is insufficient to meet the initial Q4 2026 readout target. The company plans to provide an updated timeline by year-end, noting that the overall trial duration remains unchanged.…more
$1.92-0.52%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report